Immune targets carry two kinds of antibody that are easy to confuse: surface markers read live by flow cytometry, where the clone and the dissociation method decide the result, and intracellular signalling proteins read on a blot or in a section, where the modified form is the interesting one. A reagent validated for one says nothing about the other, and the datasheet's application list is the thing to read first.
A cd14 antibody and a cd163 antibody on monocytes and macrophages
Both are read as lineage and polarisation markers, and both are shed from the surface, which has a practical consequence: soluble forms circulate and accumulate in conditioned medium, so a flow result and an ELISA on the same culture can disagree honestly. Enzymatic dissociation cleaves the epitopes several clones use, so non-enzymatic release or a brief accutase step preserves staining. For tissue, the pattern rather than the intensity is the readout, and a macrophage-rich control section is what shows the reagent worked.
A cd3e antibody and a cd8 antibody on T cells
Epsilon chain and coreceptor antibodies are the backbone of T cell panels, and the choice is made on the panel rather than on the antigen: which fluorophore is free, how bright it needs to be against that antigen's density, and whether the clone is validated for the fixation and permeabilisation the panel uses if intracellular markers are included. Both antigens are also therapeutic and diagnostic targets, so catalogues carry function-blocking and depleting clones that are not interchangeable with staining reagents.
A cd9 antibody and a cd34 antibody on surfaces
Tetraspanins are broadly expressed and are read mostly as exosome and vesicle markers, where the honest experiment reports the marker on a defined vesicle preparation rather than in a lysate. Progenitor markers such as CD34 are read as a percentage of a gated population, and the number is sensitive to the gating strategy, the viability dye and the enzyme used to free the cells from tissue. For both, an isotype control and a known negative population do more than a titration curve.
A nod2 antibody and a dectin-1 antibody on pattern recognition
Pattern recognition receptors are expressed at low copy number and their antibodies have a difficult reputation: several widely used clones detect bands that persist in knockout cells. So specificity evidence has to be genetic rather than peptide competition. The cytoplasmic sensors are read by localisation and by downstream signalling, which means a stimulated positive control with a documented ligand and time point, and the lectin receptors are read on the surface, where the fixation decides whether the epitope survives.
A cgas antibody and a samhd1 antibody on nucleic acid sensing
Cytosolic DNA sensing and restriction factors are read for localisation, modification and, in the case of the restriction factor, phosphorylation state, since that is what switches its activity. Both require nuclear and cytoplasmic fractionation to say anything about compartment, and both are interferon inducible, so an untreated control and a stimulated one belong on the same blot. A clone that recognises the protein only in its unmodified form will report a fall that is a modification rather than a loss.
An il1 beta antibody and a tnf antibody on cytokines
Cytokine antibodies come in three products with different purposes: a detection reagent for a blot or a plate, a matched pair for a quantitative assay, and a neutralising clone for blocking experiments. Interleukin 1 beta additionally exists as a precursor and a cleaved mature form, and a clone may see one or both, which changes the conclusion of any inflammasome experiment. Neutralising reagents are specified by the concentration that blocks a stated bioassay, not by affinity alone.
A trem1 antibody and a cx3cr1 antibody on myeloid receptors
Receptors expressed at modest density need bright fluorophores and careful titration, and both of these are shed or internalised on activation, so a fall in staining is not necessarily a fall in expression. Chemokine receptor antibodies are notoriously clone dependent because the epitopes sit in short extracellular loops, and ligand-based reagents are sometimes used instead. Where the receptor's level is the readout, run the ligand binding or the transcript beside the stain rather than resting on one clone.
A pd1 antibody and an ido antibody on checkpoints
Checkpoint reagents divide into staining clones and blocking clones, and the blocking ones are often the same molecules used therapeutically, which is why catalogues list biosimilar forms with their own specifications. For staining, the receptor is induced on activation, so the control is a resting against a stimulated sample rather than a positive cell line. The metabolic enzyme is intracellular and interferon induced, so its antibody is read after stimulation with fractionation or immunohistochemistry rather than on a resting lysate.
Questions people ask about irf5 antibody
What evidence proves a pattern recognition receptor antibody?
Knockout or knockdown material beside wild type. Several widely used clones detect bands that remain in cells lacking the gene.
Why do flow and ELISA disagree on a shed marker?
Because the soluble form accumulates in medium while the surface form falls. Both readings can be right, and the experiment should state which it measures.
Staining clone or blocking clone?
Different products. A blocking clone is specified by the concentration that inhibits a stated bioassay; a staining clone by its performance in flow or tissue.